Interference Assessment of Various Endogenous and Exogenous Substances on the Performance of the Eversense Long-Term Implantable Continuous Glucose Monitoring System

Diabetes Technology&Therapeutics, Ahead of Print.

Source: Diabetes Technology - March 30, 2018 Category: Endocrinology Authors: Carrie Lorenz Wendolyn Sandoval Mark Mortellaro Source Type: research